News

Onward’s Arc-IM Lumbar Lead was used in its first human patient, the company said March 26. Dr. Jocelyn Bloch performed the ...
Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...
Nyxoah has introduced its Genio neurostimulator, which is intended for obstructive sleep apnoea (OSA) treatment in England, with the first two implants carried out at University College London ...
US-based medical device company Valencia Technologies has received a strategic investment of up to $35m and appointed James ...
With its FDA-approved neurostimulator implant aimed at helping patients recover from stroke, MicroTransponder has raised $65 million in venture capital funding to expand its commercial reach.
Tinnitus, the sensation of hearing sound without an external source, can affect nearly half of people in some studies. This ...
Orion system completed a 6-year Early Feasibility Study in 2024 with positive safety and efficacy results. Spin-off is expected to be finalized by or before Q3 2025. With stocks plunging, steady ...
These include cables for daily heart rate monitors and ultra-thin wires for neurostimulator implants and cardiac pacemakers.
Penn State Health Milton S. Hershey Medical Center is Pennsylvania's first hospital to offer BrainSense adaptive deep brain stimulation for Parkinson’s Disease.
Cortigent’s Orion ® artificial vision system, which is in development to treat blindness, completed an initial 6-year clinical study in 2024, with encouraging safety and efficacy results ...